globalbarry. Company Intelligence Engine

Taysha Gene Therapies, Inc.

TSHA CIK 0001806310 · Biological Products, (No Diagnostic Substances) (SIC 2836)

Disclosed SEC business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247

Taysha Gene Therapies, Inc. (ticker TSHA, CIK 0001806310) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Biological Products, (No Diagnostic Substances) (SIC 2836). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.

Top findings public preview

  • FACT Disclosed industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
  • FACT Country of disclosed business address: United States
  • FACT SCHEDULE 13G/A filed 2026-08-14 source ↗

Go deeper

This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 5 free company deep views left this month.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.